CY1117441T1 - Αρυλοαιθινυλο παραγωγα - Google Patents
Αρυλοαιθινυλο παραγωγαInfo
- Publication number
- CY1117441T1 CY1117441T1 CY20161100357T CY161100357T CY1117441T1 CY 1117441 T1 CY1117441 T1 CY 1117441T1 CY 20161100357 T CY20161100357 T CY 20161100357T CY 161100357 T CY161100357 T CY 161100357T CY 1117441 T1 CY1117441 T1 CY 1117441T1
- Authority
- CY
- Cyprus
- Prior art keywords
- ethylene derivative
- aryl ethylene
- formula
- aryl
- derivative
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/42—Oxazoles
- A61K31/422—Oxazoles not condensed and containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
- C07D491/10—Spiro-condensed systems
- C07D491/107—Spiro-condensed systems with only one oxygen atom as ring hetero atom in the oxygen-containing ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D498/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D498/04—Ortho-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- General Chemical & Material Sciences (AREA)
- Psychiatry (AREA)
- Hospice & Palliative Care (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Plural Heterocyclic Compounds (AREA)
- Pyridine Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Thiazole And Isothizaole Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Abstract
Η παρούσα εφεύρεση σχετίζεται με αιθινυλο παράγωγα του τύπου (I) ως αλλοστερικούς ρυθμιστές του μεταβοτροπικού γλουταμινικού υποδοχέα υποτύπου 5 (mGluR5). Οι μεταβλητές του τύπου (I) καθορίζονται στην περιγραφή.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP10159754 | 2010-04-13 | ||
EP11713288.6A EP2558457B1 (en) | 2010-04-13 | 2011-04-11 | Arylethynyl derivatives |
Publications (1)
Publication Number | Publication Date |
---|---|
CY1117441T1 true CY1117441T1 (el) | 2017-04-26 |
Family
ID=44140916
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CY20161100357T CY1117441T1 (el) | 2010-04-13 | 2016-04-27 | Αρυλοαιθινυλο παραγωγα |
Country Status (33)
Country | Link |
---|---|
US (4) | US8420661B2 (el) |
EP (1) | EP2558457B1 (el) |
JP (1) | JP5559418B2 (el) |
KR (1) | KR101431367B1 (el) |
CN (1) | CN102947289B (el) |
AR (1) | AR080878A1 (el) |
AU (1) | AU2011240131B2 (el) |
BR (1) | BR112012026004A2 (el) |
CA (1) | CA2786216C (el) |
CL (1) | CL2012002771A1 (el) |
CR (1) | CR20120480A (el) |
CY (1) | CY1117441T1 (el) |
DK (1) | DK2558457T3 (el) |
EC (1) | ECSP12012212A (el) |
ES (1) | ES2565761T3 (el) |
HK (1) | HK1179607A1 (el) |
HR (1) | HRP20160617T1 (el) |
HU (1) | HUE027105T2 (el) |
IL (1) | IL220982A (el) |
MA (1) | MA34078B1 (el) |
MX (1) | MX2012011841A (el) |
MY (1) | MY160490A (el) |
NZ (1) | NZ601024A (el) |
PE (1) | PE20130155A1 (el) |
PL (1) | PL2558457T3 (el) |
RS (1) | RS54708B1 (el) |
RU (1) | RU2573560C2 (el) |
SG (1) | SG183974A1 (el) |
SI (1) | SI2558457T1 (el) |
TW (1) | TWI445706B (el) |
UA (1) | UA107491C2 (el) |
WO (1) | WO2011128279A1 (el) |
ZA (1) | ZA201207285B (el) |
Families Citing this family (29)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2010104818A1 (en) * | 2009-03-09 | 2010-09-16 | Bristol-Myers Squibb Company | Aza pyridone analogs useful as melanin concentrating hormone receptor-1 antagonists |
US8420661B2 (en) * | 2010-04-13 | 2013-04-16 | Hoffmann-La Roche Inc. | Arylethynyl derivatives |
SI2702051T1 (sl) * | 2011-04-26 | 2015-06-30 | F. Hoffmann-La Roche Ag | Etinilni derivati kot pozitivni alosteriäśni modulatorji mglur5 |
US20130123254A1 (en) * | 2011-09-30 | 2013-05-16 | Barbara Biemans | Pharmaceutically acceptable mglur5 positive allosteric modulators and their methods of identification |
UA110862C2 (uk) * | 2011-10-07 | 2016-02-25 | Ф. Хоффманн-Ля Рош Аг | Похідні етинілу як алостеричні модулятори метаботропного рецептора глутамату mglur 5 |
PE20150184A1 (es) * | 2012-07-17 | 2015-02-13 | Hoffmann La Roche | Derivados de ariletinilo |
UA113223C2 (xx) * | 2012-08-13 | 2016-12-26 | Арилетинілпіримідини | |
MX366136B (es) * | 2012-09-27 | 2019-06-28 | Hoffmann La Roche | Derivados de ariletinilo. |
UA116023C2 (uk) | 2013-07-08 | 2018-01-25 | Ф. Хоффманн-Ля Рош Аг | Етинільні похідні як антагоністи метаботропного глутаматного рецептора |
AU2014327504B2 (en) * | 2013-09-25 | 2018-01-04 | F. Hoffmann-La Roche Ag | Ethynyl derivatives |
TWI649310B (zh) * | 2014-01-10 | 2019-02-01 | 赫孚孟拉羅股份公司 | 乙炔基衍生物 |
SI3110802T1 (sl) * | 2014-02-25 | 2019-01-31 | F. Hoffmann-La Roche Ag | Derivati etinila |
EP3271353B1 (en) * | 2015-03-19 | 2019-11-27 | H. Hoffnabb-La Roche Ag | 3-(4-ethynylphenyl)hexahydropyrimidin-2,4-dione derivatives as modulators of mglur4 |
UA120309C2 (uk) * | 2015-06-03 | 2019-11-11 | Ф. Хоффманн-Ля Рош Аг | Етинільні похідні |
RS58929B1 (sr) * | 2015-07-15 | 2019-08-30 | Hoffmann La Roche | Derivati etinila kao modulatori metabotropnih glutamatnih receptora |
AR105556A1 (es) * | 2015-08-03 | 2017-10-18 | Hoffmann La Roche | Derivados de etinilo |
CN106632243B (zh) * | 2015-10-28 | 2019-03-15 | 华领医药技术(上海)有限公司 | 吡咯烷衍生物 |
RU2745068C2 (ru) | 2016-07-18 | 2021-03-18 | Ф. Хоффманн-Ля Рош Аг | Производные этинила |
CN108947883A (zh) * | 2017-05-25 | 2018-12-07 | 北京万全德众医药生物技术有限公司 | 布瓦西坦的制备 |
JP7191045B2 (ja) | 2017-06-02 | 2022-12-16 | エフ・ホフマン-ラ・ロシュ・アクチェンゲゼルシャフト | 化合物 |
WO2018220149A1 (en) | 2017-06-02 | 2018-12-06 | F. Hoffmann-La Roche Ag | Compounds |
MX2020014085A (es) | 2018-06-29 | 2021-03-09 | Hoffmann La Roche | Compuestos. |
MA53219A (fr) | 2018-08-13 | 2021-11-17 | Hoffmann La Roche | Nouveaux composés hétérocycliques en tant qu'inhibiteurs de monoacylglycérol lipase |
JP2021533093A (ja) * | 2018-08-13 | 2021-12-02 | エフ.ホフマン−ラ ロシュ アーゲーF. Hoffmann−La Roche Aktiengesellschaft | モノアシルグリセロールリパーゼ阻害剤としての新規複素環化合物 |
WO2020048826A1 (en) | 2018-09-03 | 2020-03-12 | Bayer Aktiengesellschaft | 5-substituted 1-oxa-3,9-diazaspiro[5.5]undecan-2-one compounds |
PE20220576A1 (es) | 2019-06-21 | 2022-04-20 | Hoffmann La Roche | Inhibidor de egfr para el tratamiento de cancer |
WO2020254547A1 (en) | 2019-06-21 | 2020-12-24 | F. Hoffmann-La Roche Ag | New egfr inhibitors |
MX2022002311A (es) | 2019-09-12 | 2022-03-25 | Hoffmann La Roche | Compuestos de 4,4a,5,7,8,8a-hexapirido[4,3-b][1,4]oxazin-3-ona como inhibidores de monoacilglicerol lipasa (magl). |
CN114018880B (zh) * | 2021-10-22 | 2024-02-27 | 杭州食疗晶元生物科技有限公司 | 基于内源活性中间体对纯净水和天然矿泉水的鉴别方法 |
Family Cites Families (22)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FI90869C (fi) * | 1986-11-14 | 1994-04-11 | Tanabe Seiyaku Co | Menetelmä lääkeaineena käyttökelpoisten imidatsolidinonijohdannaisten valmistamiseksi |
GB9510744D0 (en) | 1995-05-26 | 1995-07-19 | Zeneca Ltd | Chemical process |
DE19546462A1 (de) * | 1995-12-13 | 1997-06-19 | Bayer Ag | Diarylacetylenketone |
TW544448B (en) * | 1997-07-11 | 2003-08-01 | Novartis Ag | Pyridine derivatives |
WO2001016121A1 (en) | 1999-08-31 | 2001-03-08 | Merck & Co., Inc. | Heterocyclic compounds and methods of use thereof |
US6599917B1 (en) * | 1999-09-28 | 2003-07-29 | Eisai Co., Ltd. | Quinuclidine compounds and drugs containing the same as the active ingredient |
JP4225787B2 (ja) * | 2001-03-27 | 2009-02-18 | エーザイ・アール・アンド・ディー・マネジメント株式会社 | N−アリール環状アミン誘導体およびそれを有効成分として含有する医薬 |
PT1622912E (pt) * | 2003-04-23 | 2009-08-17 | Schering Corp | Antagonistas 2-alcinil- e 2-alcenilpirazolo-[4,3-b]-1,2,4- triazolo-[1,5-c]-pirimidina do receptor a2a da adenosina |
GB0325956D0 (en) | 2003-11-06 | 2003-12-10 | Addex Pharmaceuticals Sa | Novel compounds |
EP1729771B1 (en) * | 2004-03-22 | 2009-10-14 | Eli Lilly & Company | Pyridyl derivatives and their use as mglu5 receptor antagonists |
JPWO2005108370A1 (ja) | 2004-04-16 | 2008-03-21 | 味の素株式会社 | ベンゼン化合物 |
AU2005336513B2 (en) * | 2004-10-07 | 2012-08-09 | Merck Sharp & Dohme Llc | Thiazolyl mGluR5 antagonists and methods for their use |
EP1809620B1 (en) | 2004-11-04 | 2010-12-29 | Addex Pharma SA | Novel tetrazole derivatives as positive allosteric modulators of metabotropic glutamate receptors |
GB0510139D0 (en) | 2005-05-18 | 2005-06-22 | Addex Pharmaceuticals Sa | Novel compounds B1 |
MX2009013169A (es) | 2007-06-03 | 2010-04-30 | Univ Vanderbilt | Moduladores alostericos positivos del mglur5 benzamida y metodos de elaboracion y uso de los mismos. |
US8853392B2 (en) | 2007-06-03 | 2014-10-07 | Vanderbilt University | Benzamide mGluR5 positive allosteric modulators and methods of making and using same |
WO2010063487A1 (en) * | 2008-12-05 | 2010-06-10 | Merz Pharma Gmbh & Co. Kgaa | Pyrazolopyrimidines, a process for their preparation and their use as medicine |
CN101544892B (zh) * | 2009-05-07 | 2012-10-03 | 石家庄诚志永华显示材料有限公司 | 一种合成二芳基乙炔类单体液晶的方法 |
TW201116532A (en) | 2009-08-05 | 2011-05-16 | Merz Pharma Gmbh & Co Kgaa | Metabotropic glutamate receptor modulators |
US8389536B2 (en) | 2009-10-27 | 2013-03-05 | Hoffmann-La Roche Inc. | Positive allosteric modulators (PAM) |
US8420661B2 (en) * | 2010-04-13 | 2013-04-16 | Hoffmann-La Roche Inc. | Arylethynyl derivatives |
UA110862C2 (uk) * | 2011-10-07 | 2016-02-25 | Ф. Хоффманн-Ля Рош Аг | Похідні етинілу як алостеричні модулятори метаботропного рецептора глутамату mglur 5 |
-
2011
- 2011-04-05 US US13/066,044 patent/US8420661B2/en active Active
- 2011-04-11 BR BR112012026004A patent/BR112012026004A2/pt not_active Application Discontinuation
- 2011-04-11 PL PL11713288.6T patent/PL2558457T3/pl unknown
- 2011-04-11 EP EP11713288.6A patent/EP2558457B1/en active Active
- 2011-04-11 TW TW100112500A patent/TWI445706B/zh not_active IP Right Cessation
- 2011-04-11 PE PE2012002013A patent/PE20130155A1/es active IP Right Grant
- 2011-04-11 HU HUE11713288A patent/HUE027105T2/en unknown
- 2011-04-11 RU RU2012145237/04A patent/RU2573560C2/ru not_active IP Right Cessation
- 2011-04-11 SI SI201130777A patent/SI2558457T1/sl unknown
- 2011-04-11 WO PCT/EP2011/055585 patent/WO2011128279A1/en active Application Filing
- 2011-04-11 SG SG2012066759A patent/SG183974A1/en unknown
- 2011-04-11 AR ARP110101210A patent/AR080878A1/es unknown
- 2011-04-11 CA CA2786216A patent/CA2786216C/en not_active Expired - Fee Related
- 2011-04-11 RS RS20160259A patent/RS54708B1/en unknown
- 2011-04-11 MX MX2012011841A patent/MX2012011841A/es active IP Right Grant
- 2011-04-11 KR KR1020127029579A patent/KR101431367B1/ko active IP Right Grant
- 2011-04-11 DK DK11713288.6T patent/DK2558457T3/en active
- 2011-04-11 MY MYPI2012004559A patent/MY160490A/en unknown
- 2011-04-11 NZ NZ601024A patent/NZ601024A/en not_active IP Right Cessation
- 2011-04-11 JP JP2013504215A patent/JP5559418B2/ja active Active
- 2011-04-11 ES ES11713288.6T patent/ES2565761T3/es active Active
- 2011-04-11 AU AU2011240131A patent/AU2011240131B2/en not_active Ceased
- 2011-04-11 CN CN201180015120.3A patent/CN102947289B/zh active Active
- 2011-04-11 MA MA35234A patent/MA34078B1/fr unknown
- 2011-11-04 UA UAA201212800A patent/UA107491C2/uk unknown
-
2012
- 2012-07-16 IL IL220982A patent/IL220982A/en active IP Right Grant
- 2012-09-24 CR CR20120480A patent/CR20120480A/es unknown
- 2012-09-28 ZA ZA2012/07285A patent/ZA201207285B/en unknown
- 2012-10-02 EC ECSP12012212 patent/ECSP12012212A/es unknown
- 2012-10-03 CL CL2012002771A patent/CL2012002771A1/es unknown
-
2013
- 2013-02-28 US US13/779,782 patent/US8513273B2/en active Active
- 2013-06-05 HK HK13106602.2A patent/HK1179607A1/xx unknown
- 2013-06-10 US US13/914,336 patent/US8618296B2/en active Active
- 2013-11-20 US US14/085,064 patent/US9315498B2/en active Active
-
2016
- 2016-04-27 CY CY20161100357T patent/CY1117441T1/el unknown
- 2016-06-07 HR HRP20160617TT patent/HRP20160617T1/hr unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CY1117441T1 (el) | Αρυλοαιθινυλο παραγωγα | |
CY1121265T1 (el) | Παραγωγα πιπεριδινονης ως αναστολεις της mdm2 για την θεραπευτικη αγωγη του καρκινου | |
CY1112465T1 (el) | Παραγωγα αμινοτριαζολης ως αγωνιστες alx | |
CY1113727T1 (el) | Παραγωγα πυριδιν-4-υλ ως ανοσορυθμιστικοι παραγοντες | |
CY1117878T1 (el) | Πυριδινo-2-αμιδια χρησιμα ως αγωνιστες του cb2 | |
CY1117147T1 (el) | Παραγωγα [1,2,3]τριαζολο[4,5-d]πυριμιδiνης ως αγωνιστες του κaνναβινοειδους υποδοχεα 2 | |
CR20120565A (es) | Indoles | |
CR20130369A (es) | Novedosos derivados heterocíclicos | |
BR112015004111A2 (pt) | novos derivados bicíclicos | |
SV2010003617A (es) | Fungicidas | |
CY1116034T1 (el) | 2-ανιλινοβενζιμιδαζολο-6-καρβοξαμιδια ως αντι-φλεγμονωδεις παραγοντες | |
HN2010000432A (es) | Derivados de 2-alquiltio-2-quinoliniloxi-acetamida como fungicidas | |
MY169043A (en) | New dihydroquinoline-2-one derivatives | |
NI201100011A (es) | Derivados de piridino - piridinonas, su preparación y su aplicación en terapéutica. | |
UY32553A (es) | Nuevos derivados de la pirrolidinadiona espiroheterocíclicos 3-sustituidos | |
BR112014010644A2 (pt) | novos derivados de aril-quinolina | |
CY1114096T1 (el) | Παραγωγα πυριδιν-2-υλ ως ανοσορρυθμιστικοι παραγοντες | |
CY1111807T1 (el) | Παραγωγα βενζοθειαζεπινης και η χρηση τους ως ρυθμιστων των υποδοχεων ampα και nmda | |
CY1113255T1 (el) | Παραγωγο 4-πυριμιδινοσουλφαμιδης | |
EA200900946A1 (ru) | Новый способ синтеза агомелатина | |
EA201101675A1 (ru) | Спироэпоксиды как промежуточные продукты синтеза | |
CY1116173T1 (el) | Ετεροαρυλικες ενωσεις ως υποκαταστατες 5-ητ4 υποδοχεων | |
CR20130431A (es) | 5-(fenil)/piridinil-etinil)-2-piridina/ 2-pirimidina-carboxamidas como moduladores de mglur5 | |
CR20130625A (es) | Derivados de la piperidina 3-espirocíclica como agonistas de receptores de la ghrelina | |
UY31070A1 (es) | Nuevos compuestos de azetidinas, composiciones conteniendolos, aplicaciones e intermedios utiles en su sintesis |